Back to STATE STREET CORP STATE STREET CORP

SPRYSPRY
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ARS PHARMACEUTICALS INC

STATE STREET CORP holds 3.7M shares of SPRY (ARS PHARMACEUTICALS INC), worth $29.9M as of 2026-Q2. The position was increased (+2.4% shares). SPRY represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$29.9M

Current Shares

3.7M

Total Value Change

+$26.7M

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+2.4%
$29.9M0.0%$8.01
29
2026-Q1
Increased
3.6M
+13.1%
$29.3M0.0%$8.87
32
2025-Q4
Increased
3.2M
+11.3%
$37.6M0.0%$11.64
32
2025-Q3
Increased
2.9M
+31.9%
$29.1M0.0%$9.72
37
2025-Q2
Increased
2.2M
+8.0%
$38.3M0.0%$18.20
31
2025-Q1
Decreased
2M
-26.1%
$25.6M0.0%$12.49
0
2024-Q4
Increased
2.7M
+34.2%
$29M0.0%$10.62
37
2024-Q3
Increased
2M
+10.4%
$29.7M0.0%$14.32
32
2024-Q2
Increased
1.9M
+15.7%
$15.8M0.0%$8.51
32
2024-Q1
Increased
1.6M
+178.1%
$16.4M0.0%$10.22
45
2023-Q4
New
576,980
-
$3.2M0.0%$5.48
37

Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used